The research with BPO using Bioeffectives such as BIO A is interesting but 2 years off producing satisfactory results for sales. I don't know where BPO will keep getting money from, if someone thinks it has the goods it will be a takeover target, currently at 1.7 cents SP.
Lets hope Ropren our main money maker starts making money now, eagerly awaiting some news on the front(like other holders) today or tomorrow at AGM.
The research with BPO using Bioeffectives such as BIO A is...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
